ABSTRACT
Background Coronavirus was detected in December 2019 in a bulk seafood shop in Wuhan, China. The original incident of COVID-19 pandemic in India was conveyed on 30th January 2020 instigating from the nation called china. As of 25th April 2020, the Ministry of Health and Family Welfare has established a total of 24, 942 incidents, 5, 210 recuperation including 1 relocation, and 779 demises in the republic.
Objective The objective of the paper is to formulate a simple average aggregated machine learning method to predict the number, size, and length of COVID-19 cases extent and wind-up period crosswise India.
Method This study examined the datasets via the Autoregressive Integrated Moving Average Model (ARIMA). The study also built a simple mean aggregated method established on the performance of 3 regression techniques such as Support Vector Regression (SVR, NN, and LR), Neural Network, and Linear Regression.
Result The results showed that COVID-19 disease can correctly be predicted. The result of the prediction shows that COVID-19 ailment could be conveyed through water and air ecological variables and so preventives measures such as social distancing, wearing of mask and hand gloves, staying at home can help to avert the circulation of the sickness thereby resulting in reduced active cases and even mortality.
Conclusion It was established that the projected method outperformed when likened to previously obtainable practical models on the bases of prediction precision. Hence, putting in place the preventive measures can effectively manage the spread of COVID-19, and also the death rate will be reduced and eventually be over in India and other nations.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author declared that they didn't receive any funds from any organization.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Paper in collection COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
0
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos